Mondelez International, Inc.

▲ Bull Case

• ◆Full cocoa normalization + volume recovery: Spot cocoa remains $3,500–5,000 through FY2027; FY2027 hedges locked in at near-current spot. Adjusted gross margin returns to 39%+ (FY2024 level); volume recovers 2–3pp as price shock laps. Adj. EPS reaches $4.00+; at 23x = $92 (+53% from $60).
• ◆Cadbury India re-rated as standalone asset: India's chocolate market grows 12–15%/yr; Cadbury holds 65–70% share and could be valued separately (like Nestlé India, HUL). Standalone Cadbury India value of $10–15B (vs. implicit $3–4B in blended MDLZ multiple) could lift total SOTP value to $85–95.
• ◆Mars-Kellanova integration disruption benefits Oreo: Dec 2025 close of Mars-Kellanova ($36B deal) creates internal disruption (overlapping salesforce, distribution changes) that typically costs acquirer 100–200bps shelf space during 18–24 month integration. MDLZ gains shelf attention as Mars-Kellanova focuses internally.

▼ Bear Case

• ◆Cocoa re-spikes in 2026: El Niño conditions or West Africa supply disruption drives spot cocoa to $7,000–8,000/tonne. FY2027 hedges placed at elevated levels; margin recovery delayed to FY2028+. Stock re-rates to 17x $2.80 adj. EPS = $47.60 (−21% from $60).
• ◆Volume erosion proves structural: Q1 2026's −0.5pp improvement may be temporary; permanent consumer trade-down to private label after +8% price increase degrades organic growth to 2–3%/yr. MDLZ's premium positioning faces structural pressure from private label and value competition.
• ◆Hershey acquisition destroys capital: Third acquisition attempt succeeds (overcoming Hershey Trust control barrier). MDLZ acquires $50B asset while at 2.8x Net Debt/EBITDA, pushing leverage to 4.0–4.5x. Dividend cut to preserve cash; stock re-rates to 13–15x distressed consumer staples.

“Is the 2027 margin recovery mechanically certain and fully visible, or is cocoa risk still open? Consensus (24% Strong Buy, 47% Buy, 29% Hold; PT ~$67) is broadly constructive but divided on timing and magnitude. The bull camp argues the hedge schedule makes 2027 gross margin recovery an accounting certainty — not a forecast but a calculation from disclosed positions. The bear camp counters: (1) 2026 hedge roll-forward could still capture elevated levels if cocoa shocks recur; (2) volume erosion may prove more durable than Q1 2026 green shoots suggest; (3) the 3.3% dividend yield means only $2/share/yr income while waiting. Our PWFV analysis ($71 vs. $60) suggests bears are over-weighting risks that are already substantially resolved.”

• ◆Cocoa spot price tracks $3,500–5,000 (monthly monitoring; recovery confirmation; VERY HIGH magnitude)
• ◆Q2–Q3 2026 earnings show volume recovery toward flat (−1pp to +0pp; HIGH magnitude)
• ◆Q4 2026 / Feb 2027 FY2027 guidance disclosed with hedge rollover cost detail (VERY HIGH magnitude)
• ◆FY2027 adj. EPS guidance ≥$3.40 announced (implies ~37% gross margin recovery; VERY HIGH magnitude)
• ◆CFO appointment (standalone replacement for Zaramella dual-hat; H2 2026; MEDIUM magnitude)
• ◆Cadbury India organic growth acceleration (double-digit track record emerging; quarterly; MEDIUM magnitude)

• ◆Cocoa re-spike to >$7,000/tonne sustained (West Africa supply disruption; LOW-MEDIUM 15% probability; HIGH severity; extends recovery to FY2028+; destroys hedge thesis timing)
• ◆Hershey acquisition (3rd approach succeeds; LOW 10% probability; VERY HIGH severity; leverage to 4x+; dividend cut; thesis breaks)
• ◆Volume erosion proves structural (permanent private label substitution; LOW-MEDIUM 20% probability; MEDIUM severity; Q1 2026 −0.5pp still negative; watch FY2026 trend)
• ◆Mars-Kellanova biscuit competition materializes (Galaxy/McVitie's shelf gains; LOW-MEDIUM 20% probability; MEDIUM severity; 18–24 months post-close for effects)
• ◆FX headwinds (strong USD / EM currency weakness; MEDIUM 30% probability; LOW-MEDIUM severity; masks hedge roll-off benefit timing)